 suppresses expression papillary endothelium psoriatic plaques mode action Cyclosporin CsA psoriasis phenotypic profile resident passenger skin cells psoriatic patients weeks CsA treatment large panel monoclonal antibodies three-step immunoperoxidase technique comparison skin biopsies psoriatic patients psoralen UVA PUVA therapy treatment protocols effective resolution psoriatic lesions phenotypic changes CsA PUVA CsA-treated patients dramatic reduction expression papillary endothelial cells density pattern phenotype inflammatory cells unchanged contrast PUVA therapy visible effect expression papillary endothelial cells significant reduction hemopoietic resident mononuclear cells epidermis results assumption CsA regimen study anti-psoriatic effect level keratinocyte events proliferation secretion mediators responsible expression papillary endothelial cells